Cheryl B. Shatz - U.S. Customs and Border Protection (CBP) has a dangerous new rule
This item is available in full to subscribers.
At this time, we ask you to confirm your subscription at www.themtnear.com, to continue accessing the only weekly paper in the Peak to Peak region to cover ALL the news you need! Simply click Confirm my subscription now!.
If you are a digital subscriber with an active, online-only subscription then you already have an account here. Just reset your password if you've not yet logged in to your account on this new site.
Otherwise, click here to view your options for subscribing.
Questions? Call us at 303-810-5409 or email info@themountainear.com.
Please log in to continue |
Dear Editor,
U.S. Customs and Border Protection (CBP) has a dangerous new rule beginning October 22 that will threaten the healthcare of millions of Americans. The rule, "Indefinite Suspension of the De Minimis Exemption for Mail Shipments," will effectively end Americans' ability to personally import their prescription medicines.
Importing prescription drugs from licensed international pharmacies is the only lifeline for seniors on limited incomes, people with high-deductible health plans, and the uninsured. That's why CBP and the FDA have allowed it for decades. Due to the much lower cost of medications in Canada and other countries, imported medicine is their only option.
Many imported drugs can be less than half the U.S. price. These necessary medicines prevent blood clots, treat diabetes, and much more. This CBP rule will cut off access to the only affordable prescription drugs for millions, and that will lead to unnecessary harm and preventable deaths.
I ask readers to immediately call or write our Senators and U.S. Representatives and demand they stop CBP from implementing any rule-making that restricts Americans from importing personal-use prescription drugs from licensed pharmacies in Canada or other countries.
Cheryl B. Shatz
Boulder